Raltegravir in pregnancy: a case series presentation

Int J STD AIDS. 2011 Jun;22(6):358-60. doi: 10.1258/ijsa.2011.010469.

Abstract

Adequate antiretroviral therapy is essential for HIV-positive pregnant women to prevent mother-to-child transmission. We report a small case series of five women receiving raltegravir as part of their antiretroviral regimen during pregnancy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use*
  • Chemoprevention / methods*
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control
  • HIV Infections / transmission
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / virology*
  • Pyrrolidinones / therapeutic use*
  • Raltegravir Potassium
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Anti-Retroviral Agents
  • Pyrrolidinones
  • Raltegravir Potassium